DaVita Profile

70.90
USD 0.54  0.77%
69%
98%

Exercise or conversion by Dennis Kogod of 110000 shares of DaVita subject to Rule 16b-3

DaVita insider trading alert for exercise of stock appreciation rights by Dennis Kogod, Pres HCP CEO DVA Int., on September 18, 2018. This event was filed by Davita Inc with SEC on 2016-05-11. Statement of changes in beneficial ownership - SEC Form 4. Dennis Kogod is currently serves as ceo of international and president of healthcare partners of DaVita [view details]   

DaVita Summary

DaVita (DVA) is traded on BATS Exchange in USA. It is located in COLORADO U.S.A and employs 74,500 people. DaVita is listed under Healthcare category by Fama And French industry classification.The company currently falls under 'Large-Cap' category with total capitalization of 11.56 B. DaVita runs under Healthcare sector within Medical Care industry. This company has 166.9 M outstanding shares of which 6.99 M shares are currently shorted by investors with about 7.13 days to cover shorted positions. DAVITA INC has about 393.79 M in cash with (4.67 B) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.36.
Check DaVita Probability Of Bankruptcy

Ownership Allocation (%)

DaVita Target Price Odds Analysis

Odds Below 70.9HorizonTargetOdds Above 70.9
66.33%30 days 70.90 33.37%
Based on normal probability distribution, the odds of DaVita to move above current price in 30 days from now is about 33.37% (This DaVita probability density function shows the probability of DaVita Stock to fall within a particular range of prices over 30 days) .

DaVita Top Holders

DaVita Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Berkshire Hathaway IncCommon Shares38.6 M2.7 B
Vanguard Group IncCommon Shares13.8 M958.7 M
Empyrean Capital Partners Lp 1Call Options2.4 M166.3 M
View DaVita Diagnostics

DaVita Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

DaVita Key Fundamentals

DaVita Against Markets

DaVita Current Ratings

DaVita 30 Days Performance Scores

Risk Adjusted
Performance Score (0 to 100)
0 
Chance of
Financial Distress (0 to 100%)
1 
Equity ratings for DaVita are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease . DaVita Inc. was founded in 1994 and is headquartered in Denver, Colorado. DaVita operates under Medical Care classification in USA and traded on BATS Exchange. It employs 74500 people. more
Fama & French Healthcare
Healthcare
Fama & French Classification
DaVita SEC Filings
DaVita SEC Filings
Security & Exchange Commission EDGAR ReportsView All
NameDaVita
CEO of Kidney Care DivisionJavier RodriguezView All
Thematic Classifications
Active Investing Ideas
Analyst Consensus
Piotroski F Score
Macroaxis Advice
Bond Rating
Specialization
Healthcare, Medical Care
InstrumentUSA Stock View All
RegionNorth America
LocationCOLORADO U.S.A
Business Address2000 16th Street
ExchangeBATS Exchange
CIK Number0000927066
ISINUS23918K1088
CUSIP89151A107
SectorHealthcare
IndustryMedical Care
BenchmarkDOW
Websitewww.davita.com
Phone303 405 2100
CurrencyUSD - US Dollar
Next Fiscal Year EndDecember 31, 2019
Most Recent QuarterJune 30, 2018
Last Fiscal Year EndDecember 31, 2017
Date Short InterestAugust 15, 2018

DaVita Directors

DaVita Corporate Directors

Paul Diaz Independent Director
John Nehra Independent Director
Peter Grauer Lead Independent Director
Additionally see Investing Opportunities. Please also try Companies Directory module to evaluate performance of over 100,000 stocks, funds, and etfs against different fundamentals.
Search macroaxis.com